A Phase 3 interventional study of Sinbaro-3 and Hwangryun in Low Back Pain With Radiculopathy, Low Back Pain Without Radiculopathy and Herniated Intervertebral Disc, sponsored by Jaseng Hospital of Korean Medicine. Completed at 1 site in Korea, Republic of. Open to participants aged 18 Years to 69 Years. Per ClinicalTrials.gov, last updated 2018-11-07.
Sponsored by Jaseng Hospital of Korean Medicine · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 27 studies in Intervertebral Disc Displacement with a site in Korea, Republic of — 4 open to participants now, 6 under way, none of them phase 3. Intervertebral Disc Displacement · Korea, Republic of.
Among the 27 studies in Intervertebral Disc Displacement with a site in Korea, Republic of, this one is the 11th largest by enrollment of the 17 interventional ones that give a count, is the only one that started in 2014, is one of 2 in phase 3, and was the 4th registered.
474 studies on the registry are indexed under Intervertebral Disc Displacement; 98 are open to participants now.
Browse Intervertebral Disc Displacement studies →4 of the 27 studies in Intervertebral Disc Displacement with a site in Korea, Republic of are open now. Recruiting first, the newest first:
Jaseng Medical Foundation · Sites in Korea, Republic of
Ages 19–69
Jaseng Hospital of Korean Medicine · Sites in Korea, Republic of
Korea University Anam Hospital · Sites in Korea, Republic of
Ages 20–60
Yonsei University · Sites in Korea, Republic of
Ages 65+
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 48 Intervertebral Disc Displacement studies recruiting now, 20 (42%) set no upper age limit and 24 (50%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.
This study: 18 Years to 69 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
27 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 1 started in 2014.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 60 is close to the median of 63 across 344 interventional studies indexed under Intervertebral Disc Displacement.
Median enrollment 69 across the 17 interventional studies, 117 across the 10 observational. Of the 19 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 27 have an industry lead sponsor. The 10 most frequent:
Jaseng Hospital of Korean Medicine is the lead sponsor of 14 studies on the registry; 1 is open to participants now.
Jaseng Hospital of Korean Medicine has 4 studies filed under Intervertebral Disc Displacement — fewer than ten, so there is no comparison to draw.
2 of the studies in Intervertebral Disc Displacement with a site in Korea, Republic of that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07280780Korea University Anam HospitalCGM-Based Glycemic Analysis After ESI | 2026-12-20 |
| NCT06178939Yonsei UniversityEffects of Cognitive Intervention Therapy on Postoperative Delirium | 2027-10 |
Add all 2 to your calendar (.ics) → With an account.
Among the 27 studies in Intervertebral Disc Displacement with a site in Korea, Republic of, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to investigate the immediate pain relieving effects of sinbaro-3 pharmaco-acupuncture in patients with low back pain admitted for inpatient care
60 patients with LBP with moderate to severe pain(NRS>6) were randomly allocated to 2 groups. The experimental group was treated with sinbaro-3 pharmacoacupuncture and the control group was treated with Hwangryun pharmacoacupuncture. All administrations were limited to 1 session, and comparisons of measurements were made before and after treatment. Primary outcomes were measured using the VAS scale. Post-treatment follow-up will be performed to measure primary outcomes at 30 minutes, 2hours, 4hours, and 6 hours after treatment. Before and after each measurement, the patients are asked to stand up and rotate their torso. At termination of the study, satisfaction levels of the patient's current status will also be collected.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
1cc Harpagophytum Procumbens(freeze drying) pharmacoacupuncture adminstered to 6 acupoints at the site of pain Administered once and once only before any interventions
Drug: Sinbaro-3
1cc Hwangryun(distillation) pharmaco-acupuncture administered to 6 acupoints at the site of pain Administered once and once only before any other intervention
Drug: Hwangryun
1cc administered to site of pain(ashi acupoints), once and once only before any other intervention/if pain in both low back and extermities, the site of most pain
Also known as: Harpagophytum Procumbens
1cc administered to site of pain(ashi acupoints), once and once only before any other intervention/if pain in both low back and extermities, the site of most pain
Visual Analogue Scale
The patient is asked to stand up and roatate the torso to the left and right, then asked to mark on the visual analogue scale the intensity of the pain they are experiencing
Time frame: At baseline
Visual Analogue Scale
The patient is asked to stand up and roatate the torso to the left and right, then asked to mark on the visual analogue scale the intensity of the pain they are experiencing
Time frame: 30 minutes following treatment
Visual Analogue Scale
The patient is asked to stand up and roatate the torso to the left and right, then asked to mark on the visual analogue scale the intensity of the pain they are experiencing
Time frame: 2 hours following treatment
Visual Analogue Scale
The patient is asked to stand up and roatate the torso to the left and right, then asked to mark on the visual analogue scale the intensity of the pain they are experiencing
Time frame: 4 hours following treatment
Visual Analogue Scale
The patient is asked to stand up and roatate the torso to the left and right, then asked to mark on the visual analogue scale the intensity of the pain they are experiencing
Time frame: 6 hours following treatment
Satisfaction levels
7-point Likert scale
Time frame: 6hrs following treatment
Expected treatment effects
The patients are asked to reply how effective they think the treatment is going to be on a 6-point Likert-scale
Time frame: At baseline
Ran from Jul 2014 to primary completion in Oct 2014, 3 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Harpagophytum procumbens
Intervertebral Disc Displacement →
Jaseng Hospital of Korean Medicine